The DOI matches its Crossref record; 29 of the 32 references it cites were found in a registry or an index.
Access to medicines: cost as an influence on the views and behaviour of patients
Abstract
The present paper explores how charges for medicines incurred by patients influence their decisions for managing acute or chronic conditions, and whether prescription cost and affordability issues are discussed in the general practitioner (GP)-patient encounter. People suffering from dyspepsia, hay fever or hypertension, or those taking hormone replacement therapy, were recruited through three community pharmacies in the North-west of England. Six focus groups were conducted with a total of 31 participants, the majority of whom were non-exempt from prescription charges. The management behaviour of those participants who had to pay for their prescriptions, particularly those from less-affluent or deprived backgrounds, was influenced by cost. However, cost was not the overriding influence, with other factors, such as symptom or disease severity, effectiveness, or necessity of treatment, playing a more important part in participants' management decisions. Cost as an issue was reflected in the various strategies used by participants to reduce medication cost, such as not having some prescribed items dispensed, taking a smaller dose or buying a cheaper over-the-counter product. Despite the use of numerous strategies, participants did not talk to their GPs about issues of cost and affordability. Participants felt that paying for prescriptions was their problem. There was a belief that discussing cost issues could jeopardise the doctor-patient relationship. Although not the dominant factor, medication cost nevertheless influenced participants when deciding how to manage their condition. Awareness of the existence of prepayment certificates, which can be bought by patients who require regular medication, was low, and this should be addressed through improved information/dissemination. Despite the high level of prescription items exempt, the current level of the prescription charge is still a barrier to obtaining prescription medicines under the National Health Service to those on lower incomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Referral implies that a GP has identified particular features of candidacy and is seeking to match those to a service that deals with that form of candidacy, but patients can resist being referred [42,63] and can resist offers of medication [64,65].”
From Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups (2006) · cites this paper as [65]
Citations
Cites
Focus Groups: A Practical Guide for Applied Research
McQuarrie, E. F., & Krueger, R. A. (1989) · Journal of Marketing Research · doi:10.2307/3172912 · Cited by 15,489
Research Methods in Health. Investigating health and health services
Bowling, A. (1997) · Research Repository (Kingston University London) · Cited by 1,636
(2002) · Routledge eBooks · doi:10.4324/9780203413081 · Cited by 1,516
The Lipid Research Clinics Coronary Primary Prevention Trial Results
(1984) · JAMA · doi:10.1001/jama.1984.03340270043026 · Cited by 1,404
Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons
Tamblyn, R. M. (2001) · JAMA · doi:10.1001/jama.285.4.421 · Cited by 874
Patient non-compliance: Deviance or reasoned decision-making?
Donovan, J. L., & Blake, D. R. (1992) · Social Science & Medicine · doi:10.1016/0277-9536(92)90206-6 · Cited by 785
Patients' unvoiced agendas in general practice consultations: qualitative study
Barry, C. A. (2000) · BMJ · doi:10.1136/bmj.320.7244.1246 · Cited by 585
Treatment adherence and risk of death after a myocardial infarction
Horwitz, R. I., Viscoli, C. M., Donaldson, R. M., Murray, C. J. L., Ransohoff, D. F., Horwitz, R. I., Berkman, L. F., Horwitz, S. M., Ransohoff, D. F., & Sindelar, J. L. (1990) · The Lancet · doi:10.1016/0140-6736(90)92095-y · Cited by 453
Prevalence of symptoms of dyspepsia in the community.
Jones, R. H., & LYDEARD, S. (1989) · BMJ · doi:10.1136/bmj.298.6665.30 · Cited by 429
Payment Restrictions for Prescription Drugs under Medicaid
Soumerai, S. B., Avorn, J., Ross‐Degnan, D., & Gortmaker, S. L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708273170906 · Cited by 409
Research works printed but not linked: 8
- Anonymous, 2000, Antihypertensive compliance and stroke risk, Pharmaceutical Journal, 10, 642
- British Medical Association General Practitioners’ Committee, 2001, The Future of Prescribing. Discussion Paper
- Department of Health, 1999, Statistics of Prescriptions Dispensed in the Community: England 1988 to 1998
- Department of Health, 2000, Pharmacy in the Future - Implementing the NHS Plan
- Hassell, 1996, The use of focus groups in pharmacy research: processes and practicalities, Journal of Social and Administrative Pharmacy, 13, 169
- Nathan, 1996, A non-prescription medicines formulary. 4. Hay fever treatments, Pharmaceutical Journal, 256, 188
- Phelps, 2001, Unhealthy Charges. CAB Evidence on the Impact of Health Charges
- Royal Pharmaceutical Society of Great Britain, 1997, From Compliance to Concordance: Achieving Shared Goals in Medicine Taking.
Cited by
Sorted by citations
Dixon-Woods, M., Cavers, D., Agarwal, S., Annandale, E., Arthur, A., Harvey, J., Hsu, R., Katbamna, S., Olsen, R., Smith, L., et al. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-35 · Cited by 2,289
Khatib, R., Schwalm, J.-D., Yusuf, S., Haynes, R. B., McKee, M., Khan, M., & Nieuwlaat, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084238 · Cited by 442
Doctor–Patient Communication, Health-Related Beliefs, and Adherence in Glaucoma
Friedman, D. S., Hahn, S. R., Gelb, L., Tan, J., Shah, S., Kim, E. E., Zimmerman, T. J., & Quigley, H. A. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.11.023 · Cited by 307
Physician Awareness of Drug Cost: A Systematic Review
Allan, G. M., Lexchin, J., & Wiebe, N. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040283 · Cited by 292
McHorney, C. A. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802619425 · Cited by 199
Wroth, T. H., & Pathman, D. E. (2006) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.19.5.478 · Cited by 154
Schoenberg, N. E., Kim, H., Edwards, W., & Fleming, S. T. (2007) · The Gerontologist · doi:10.1093/geront/47.4.423 · Cited by 126
Impact of Concurrent Medication Use on Statin Adherence and Refill Persistence
Grant, R. W., O'Leary, K. M., Weilburg, J. B., Singer, D. E., & Meigs, J. B. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.21.2343 · Cited by 117
Strategies for Coping in a Complex World: Adherence Behavior Among Older Adults with Chronic Illness
Elliott, R. A., Ross‐Degnan, D., Adams, A. S., Safran, D. G., & Soumerai, S. B. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0193-5 · Cited by 102
Determinants of Self-Reported Medicine Underuse Due to Cost: A Comparison of Seven Countries
Kemp, A., Roughead, E. E., Preen, D. B., Glover, J. D., & Semmens, J. B. (2010) · Journal of Health Services Research & Policy · doi:10.1258/jhsrp.2009.009059 · Cited by 76
Kennedy, J. J., & Morgan, S. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.07.009 · Cited by 71
Cost-Effectiveness of Adherence-Enhancing Interventions: A Quality Assessment of the Evidence
Elliott, R. A., Barber, N., & Horne, R. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e398 · Cited by 71
Kahn, S. R., Elman, E. E., Rodger, M. A., & Wells, P. S. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00098.x · Cited by 67
Understanding Medication Compliance and Persistence from an Economics Perspective
Elliott, R. A., Shinogle, J. A., Peele, P. B., Bhosle, M. J., & Hughes, D. A. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00304.x · Cited by 61
Amonov, M., Yoshida, Y., Erkin, T., Salim, D., & Hamajima, N. (2014) · Europe PMC (PubMed Central) · doi:10.18999/nagjms.76.3-4.255 · Cited by 63
Bokhour, B. G., Cohn, E. S., Cortés, D. E., Yinusa-Nyahkoon, L. S., Hook, J. M., Smith, L. A., Rand, C. S., & Lieu, T. A. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2007.11.007 · Cited by 55
Treatment adherence and clinical outcome in systemic lupus erythematosus
Chambers, S., Rahman, A., & Isenberg, D. A. (2007) · Rheumatology · doi:10.1093/rheumatology/kem016 · Cited by 55
Davey, P. G., Ferech, M., Ansari, F., Müller, A., & Goossens, H. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn386 · Cited by 55
Fredrickson, D. D., Molgaard, C. A., Dismuke, S. E., Schukman, J., & Walling, A. (2004) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.17.2.96 · Cited by 54
Poor Adherence to Medication in Adults with Rheumatoid Arthritis
Elliott, R. A. (2008) · Disease Management & Health Outcomes · doi:10.2165/00115677-200816010-00003 · Cited by 56
Prevalence of Hypertension among Urban Slum Dwellers in Lagos, Nigeria
Daniel, O. J., Adejumo, O. A., Adejumo, E. N., Owolabi, R. S., & Braimoh, R. W. (2013) · Journal of Urban Health · doi:10.1007/s11524-013-9795-x · Cited by 50
Affordability of Medicines and Patients??? Cost-Reducing Behaviour
Atella, V., Schafheutle, E. I., Noyce, P., & Hassell, K. (2005) · Applied Health Economics and Health Policy · doi:10.2165/00148365-200504010-00005 · Cited by 46
Self-citationHolbrook, A. M., Wang, M., Lee, M., Chen, Z., Garcia, M. C., Nguyen, L. N., Ford, A., Manji, S., & Law, M. R. (2021) · Systematic Reviews · doi:10.1186/s13643-020-01558-5 · Cited by 45
Akl, C., Akik, C., Ghattas, H., & Obermeyer, C. M. (2020) · BMC Public Health · doi:10.1186/s12889-020-08678-6 · Cited by 42
Hassell, K. (2003) · European Journal of Public Health · doi:10.1093/eurpub/13.1.18 · Cited by 38
Self-citationHarrington, N. G., Scott, A. M., & Spencer, E. A. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113084 · Cited by 37
Bauler, S., Jacquin-Courtois, S., Haesebaert, J., Luaute, J., Coudeyre, E., Feutrier, C., Allenet, B., Decullier, E., Rode, G., & Janoly-Dumenil, A. (2014) · European Neurology · doi:10.1159/000362718 · Cited by 36
Moral hazard and prescription medicine use in Australia—the patient perspective
Doran, E., Robertson, J., & Henry, D. A. (2004) · Social Science & Medicine · doi:10.1016/j.socscimed.2004.08.005 · Cited by 33
Sakhuja, S., Colvin, C. L., Akinyelure, O. P., Jaeger, B. C., Foti, K. E., Oparil, S., Hardy, S. T., & Muntner, P. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17590 · Cited by 30
Jayasooriya, N., Blackwell, J., Saxena, S., Bottle, A., Petersen, I., Creese, H., Hotopf, M., Pollok, R. C. G., & POP‐IBD study group (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16820 · Cited by 27
“26 We found a third of individuals with IBD that started an antidepressant received only a single prescription, consistent with findings in the general population.”
Patient co‐payments and use of prescription medicines
Doran, E., Robertson, J., Rolfe, I. E., & Henry, D. A. (2004) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2004.tb00634.x · Cited by 28
Bauler, S., Jacquin‐Courtois, S., Haesebaert, J., Luauté, J., Coudeyre, E., Feutrier, C., Allenet, B., Decullier, É., Gilles Rode, A., & Janoly-Duménil, A. (2014) · HAL · Cited by 27
Shrestha, S., Shakya, R., Karmacharya, B., & Thapa, P. (2015) · Kathmandu University Medical Journal · doi:10.3126/kumj.v11i3.12510 · Cited by 36
Effect of depression onset on adherence to medication among hypertensive patients
Sjösten, N., Nabi, H., Westerlund, H., Salo, P., Oksanen, T., Pentti, J., Virtanen, M., Mika Kivimaki, B., & Vahtera, J. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32836098d1 · Cited by 26
Refill non-adherence to repeat prescriptions leads to treatment gaps or to high extra costs
Krigsman, K., Melander, A., Carlsten, A., Ekedahl, A., & Nilsson, J. L. G. (2007) · Pharmacy World & Science · doi:10.1007/s11096-005-4797-8 · Cited by 26
Kendzerska, T., Gershon, A. S., TOMLINSON, G. A., & Leung, R. S. T. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201505-294oc · Cited by 26
Castillo-Laborde, C., Hirmas, M., Matute, I., Jasmen, A., Urrejola, Ó., Molina, X., Awad, C., Frey-Moreno, C., Pumarino-Lira, S., Fernando Descalzi, M., et al. (2022) · Public health reviews · doi:10.3389/phrs.2022.1604796 · Cited by 23
Gupta, D., Ehrlich, J. R., Newman-Casey, P. A., & Stagg, B. C. (2020) · Ophthalmology Glaucoma · doi:10.1016/j.ogla.2020.08.010 · Cited by 22
Poor Adherence to Anti-inflammatory Medication in Asthma
Elliott, R. A. (2006) · Disease Management & Health Outcomes · doi:10.2165/00115677-200614040-00005 · Cited by 22
Keskin, M., Kelly, C. P., Moreira-Gonzalez, A., Lobocki, C. A., Yarım, M., Kaplan, S., & Jackson, I. T. (2008) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e31817d6206 · Cited by 22
Non-dispensing of NHS prescriptions in community pharmacies
Schafheutle, E. I., Hassell, K., Em, S., & Noyce, P. (2002) · International Journal of Pharmacy Practice · doi:10.1111/j.2042-7174.2002.tb00582.x · Cited by 21
Self-citationVogler, S., Dedet, G., & Pedersen, H. B. (2019) · Applied Health Economics and Health Policy · doi:10.1007/s40258-019-00509-z · Cited by 20
Chen, L., Schafheutle, E. I., & Noyce, P. (2009) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2008.08.003 · Cited by 20
Self-citationCoping with prescription charges in the UK
Schafheutle, E. I., Hassell, K., & Noyce, P. (2004) · International Journal of Pharmacy Practice · doi:10.1211/0022357044995 · Cited by 20
Self-citationThe seed of abundance and misery
Twrdek, L., & Manzel, K. (2010) · Economics & Human Biology · doi:10.1016/j.ehb.2010.05.012 · Cited by 21
Is the level of patient co-payment for medicines associated with refill adherence in Sweden?
Lesén, E., Sundell, K. A., CARLSTEN, A., MÅRDBY, A.-C. M., & Jönsson, A. K. (2013) · European Journal of Public Health · doi:10.1093/eurpub/ckt062 · Cited by 18
Influences on community nurse prescribing
Hall, J. P. W. ., Cantrill, J. A., & Noyce, P. (2003) · Nurse Prescribing · doi:10.12968/npre.2003.1.3.11365 · Cited by 17
Self-citationKava, C. M., Fishleder, S., Steinman, L. E., Petrescu-Prahova, M. G., Schrodt, L. A., & Harris, J. R. (2019) · Journal of Applied Gerontology · doi:10.1177/0733464819847402 · Cited by 16
Sinnott, S., Guinane, M., Whelton, H. P., & Byrne, S. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-16 · Cited by 16
Mendoza, J. A., Silva, F., Rangel, L. M., Jaramillo, L., Mendoza, L., Garzon, J., & Quiroga, A. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196361 · Cited by 15
Improving eye drop treatment for glaucoma through better adherence.
Quigley, H. (2008) · Optometry and Vision Science · doi:10.1097/opx.0b013e318177ec17 · Cited by 19
Discussing patients’ insurance and out-of-pocket expenses during GPs’ consultations
Victoor, A., Noordman, J., Potappel, A., Meijers, M. C., Kloek, C. J. J., & de Jong, J. D. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-3966-8 · Cited by 13
Schafheutle, E. I. (2009) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2009.00012 · Cited by 13
Self-citationImpacto de intervenções para promoção do uso de medicamentos genéricos: revisão sistemática
Guttier, M. C., Silveira, M. P. T., Luiza, V. L., & Bertoldi, A. D. (2017) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232017228.05762017 · Cited by 11
Patients' views on the UK policy of prescription charges—Insights from qualitative interviews
Schafheutle, E. I. (2008) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2008.02.001 · Cited by 11
Self-citationWhat influences seniors' choice of medications for osteoarthritis? Qualitative inquiry.
Bower, K. N., Frail, D. M., Twohig, P. L., & Putnam, W. (2006) · PubMed Central · Cited by 11
Ahmad, N. S., Hatah, E., Jalil, M. R., & Makmor‐Bakry, M. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.589734 · Cited by 12
TAKVİYE EDİCİ GIDA REKLAMLARINDA ALDATICI UNSURLAR
Kazaz, A., & ERDOĞAN, M. G. (2020) · Gümüşhane Üniversitesi İletişim Fakültesi Elektronik Dergisi · doi:10.19145/e-gifder.722025 · Cited by 10
Ungar, W. J., MacDonald, T., & Cousins, M. A. (2005) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2005.06.004 · Cited by 10
Gikunda, C. N., Gitonga, L. K., & Kamweru, P. K. (2021) · Open Journal of Clinical Diagnostics · doi:10.4236/ojcd.2021.112002 · Cited by 8
Coping Strategies Used by Patients Infected with Hepatitis C Virus Who Are Facing Medication Costs
SKETRIS, I. S., Sanyal, C., Ingram, E. L., Peltekian, K. M., & Kirkland, S. (2011) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v64i2.997 · Cited by 8
Pirasath, S., Sugathapala, A. G. H., & Wanigasuriya, K. P. (2020) · International Journal of Hypertension · doi:10.1155/2020/1320109 · Cited by 9
Role of Cost on Failure to Access Prescribed Pharmaceuticals: The Case of Statins
McRae, I., Gool, K. V., Hall, J. P., & Yen, L. E. (2017) · Applied Health Economics and Health Policy · doi:10.1007/s40258-017-0336-8 · Cited by 8
O’Brien, G. L., Sinnott, S., Flynn, B. O., Walshe, V., Mulcahy, M., & Byrne, S. (2020) · Health Policy · doi:10.1016/j.healthpol.2020.02.011 · Cited by 7
Tackling reimbursement challenges to fair access to medicines – introduction to the topic
Tachkov, K., Savova, A., Manova, M. M., & Petrova, G. I. (2023) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2023.2203384 · Cited by 7
Al‐Windi, A. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0615-1 · Cited by 8
Chen, L., Lee, Y.-Y., Lin, T., Lee, C.-S., Li, C.-J., & Wu, D. (2012) · Value in Health Regional Issues · doi:10.1016/j.vhri.2012.03.010 · Cited by 7
Sauveur, R. S., Sufra, R., Pierre, M. C. J., Inddy, J., Jean, M., Mourra, N., Sundararajan, R. L., McNairy, M. L., Pape, J. W., Rouzier, V., et al. (2025) · BMC Public Health · doi:10.1186/s12889-024-20793-2 · Cited by 5
Holst, J. (2008) · RePEc: Research Papers in Economics · Cited by 5
Atella, V., Noyce, P., Schafheutle, E. I., & Hassell, K. (2005) · SSRN Electronic Journal · doi:10.2139/ssrn.648009 · Cited by 5
Self-citationStudy on Variations in Price of Prescription Medicines in Thailand
Burapadaja, S., Kawasaki, N., Kittipongpatana, O. S., & Ogata, F. (2007) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.127.515 · Cited by 4
Dhippayom, T., & Walker, R. S. (2008) · Health Policy · doi:10.1016/j.healthpol.2008.01.006 · Cited by 4
Is limiting rather than abolishing prescription charges the answer
Schafheutle, E. I. (2006) · Research Explorer (The University of Manchester) · Cited by 4
Self-citationInvestigation of advantages and disadvantages of OTC drug group
Kartal, N., & Arısoy, S. (2017) · Sağlık akademisyenleri dergisi/Sağlık akademisyenler dergisi · doi:10.5455/sad.13-1508913356 · Cited by 4
Influence of prescription charges on repeat prescribing in primary care
Bradley, F., Elvey, R., Ashcroft, D. M., & Noyce, P. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00821.x · Cited by 3
Self-citationStephens, P. N., & Leufkens, H. G. M. (2014) · Journal of Generic Medicines The Business Journal for the Generic Medicines Sector · doi:10.1177/1741134315569894 · Cited by 3
Knowledge and attitudes to prescription charges in New Zealand and England
Norris, P., Wilson, S. E., Green, J., Gu, J. Y. J., Goddard, S., Deadman, L. R., Dai, J., Fastier, K., Kothapally, C., Shi, W., et al. (2017) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2017.02.016 · Cited by 3
Maddox, C. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 3
Garg, A. X., Singh, A. R., Kadukkatt, S. S., Pablo, J., & Akku, S. (2019) · Journal of Generic Medicines The Business Journal for the Generic Medicines Sector · doi:10.1177/1741134319833122 · Cited by 2
The multifaceted nature of access to compounded progesterone: A cross-sectional study from Australia
Spark, M. J., Willis, J., Byrne, G., & Iacono, T. A. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.10.016 · Cited by 2
Herrmann, W., Haarmann, A., & Bærheim, A. (2017) · Family Practice · doi:10.1093/fampra/cmx092 · Cited by 2
MHADI, A. A., Ong, S. C., & Abed, Y. A. (2023) · Journal of Research in Pharmacy · doi:10.29228/jrp.329 · Cited by 2
Holst, J. (2010) · RePEc: Research Papers in Economics · Cited by 2
Removing Prescription Charges for Patients with Mental Health Disorders
Schafheutle, E. I. (2006) · Disease Management & Health Outcomes · doi:10.2165/00115677-200614030-00002 · Cited by 2
Self-citationEncouraging pharmaceutical innovation to meet the needs of both developed and developing countries
Longo, C. J. (2011) · International Journal of Development Issues · doi:10.1108/14468951111123346 · Cited by 1
Mendhe, H. G., Makade, K. G., Bhawnani, D., Narni, H., & Singh, D. (2017) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20172650 · Cited by 1
Farid, N., Shah, M., Ali, A., & Jan, D. (2021) · Journal of Medical Sciences · doi:10.52764/jms.21.29.1.11 · Cited by 1
Determinants and Barriers to Adherence in Hypertension
Ogna, V. F., & Burnier, M. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-76593-8_9 · Cited by 1
Perceptions and Challenges for Adoption of Generics and Biosimilars in Oncology
Garg, A. X., Deepak, C. S. N., & Jandoo, T. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85587 · Cited by 1
Tissue-Engineering von respiratorischem Epithel
Bücheler, M., Foerster, U., Haisch, A., Bootz, F., Lang, S., & Rotter, N. (2008) · HNO · doi:10.1007/s00106-008-1677-2 · Cited by 1
The impact of user charges on patient choice of healthcare services in Ireland
Fox, A. (2016) · Arrow@dit (Dublin Institute of Technology) · Cited by 1
Determinants of oral medication compliance in osteoporosis: the role of medication beliefs.
Schousboe, J. T. (2009) · University of Minnesota Digital Conservancy (University of Minnesota)
Patient Communication and the Glaucoma Surgeon
Bhartiya, S., & Ichhpujani, P. (2011) · JOURNAL OF CURRENT GLAUCOMA PRACTICE · doi:10.5005/jp-journals-10008-1122
Cost as a Feature of Medication Management Communication in Medical Visits
Beard, A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/wy5x-5r81
Saiful, A., Ithnin, M., Rani, M. D. M., Noh, N. A., Hamid, N. A., Mohamed, I. N., Al-Naggar, R. A., & Aripin, K. N. N. (2016) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v15i4.28
Compliance of Diabetic Patients: Pros and Cons
Taher, E., Hamdy, G., Sultan, S., & Moustafa, H. A. M. (2008) · Journal of High Institute of Public Health · doi:10.21608/jhiph.2008.20984
Telling Patients What They Want to Hear: Talking about the Cost of Healthcare
O'Toole, T. P. (2004) · Advanced studies in medicine
What patients pay for medicines: a comparison of six countries
Herd, C. E. (2017) · Otago University Research Archive (University of Otago)
Reichl, V. (2005) · Deutscher Universitätsverlag eBooks · doi:10.1007/978-3-322-82177-5_9
Metadata
- Authors
- Schafheutle, E. I., Hassell, K., & Noyce, P. R.
- Affiliations
- University of Manchester (GB)
- Venue
- Health & Social Care in the Community
- Publisher
- Hindawi Limited
- Published
- 2002-04-30
- Volume
- 10
- Issue
- 3
- Pages
- 187-195
- ISSN
- 0966-0410 (ISSN-L)
- OpenAlex
- W2076062096
- Cited by
- 105
- References
- 32
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 2 · 2022: 2 · 2021: 7 · 2020: 7 · 2019: 6 · 2018: 2 · 2017: 7 · 2016: 2 · 2015: 2 · 2014: 5 · 2013: 5 · 2012: 1
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Health & Social Care in the Community (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Systems and Reforms
- Keywords
- prescription charges, drug affordability, patient decision-making, socioeconomic deprivation, physician-patient relationship, dyspepsia, allergic rhinitis, hypertension, hormone replacement therapy, National Health Service
- MeSH terms
- Adult, Aged, Aged, 80 and over, Communication, Decision Making, England, Fees, Pharmaceutical, Female, Health Services Accessibility, Humans, Male, Middle Aged, Patient Compliance, Physician-Patient Relations, Cost Sharing, Focus Groups, Drugs, Essential
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review